Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02897908 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 2026 to Apr 2027v10
  2. Re-verified, no change to tracked fieldsv9
  3. Site contact updatedv8
  4. 3 versions Re-verified since Oct 27, 2020, no change to tracked fieldsv5-v7
  5. Study site revisedv4
Show 2 earlier versionsHide 2 earlier versions
  1. Re-verified, no change to tracked fieldsv3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Study completion date: Dec 2026
    • Start date: Sep 2016 to Oct 28, 2016
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary goal of this study is to establish a database of people with varying levels of hepatic fibrosis and various etiologies of liver disease for use in future research protocols.
Trial Details
NCT Number NCT02897908
Lead Sponsor State University of New York at Buffalo
Collaborators: Kaleida Health
Conditions
(from sponsor)		 Disease of Liver and Bile Duct
Related terms Digestive System Diseases
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov